Skip to content
Biodatica
Start free

Investigator

Hae Lin Jang

BRIGHAM AND WOMEN'S HOSPITAL · funded by NIDCR, NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.6M

Summed across those awards.

First award
Sep 1, 2022

Latest Jul 1, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss

    $814k

    Jul 1, 2023NIDCRBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11077887 (opens the source filing in a new tab)

  2. R01

    A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss

    $814k

    Jul 1, 2023NIDCRBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11318988 (opens the source filing in a new tab)

  3. R42

    Next generation anti-cancer drugdelivering cement for bone metastasis patients

    $1.0M

    Sep 1, 2022NCICURER INCNIH RePORTER · 11177833 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources